Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.

Palmer SM, Davis RD, Hadjiliadis D, Hertz MI, Howell DN, Ward FE, Savik K, Reinsmoen NL.

Transplantation. 2002 Sep 27;74(6):799-804.

PMID:
12364858
2.

Immunology at Duke.

Ward FE, Tedder TF.

Immunol Res. 2000;22(2-3):67-9. No abstract available.

PMID:
11339366
3.

Cellular immunology markers postransplantation predictive of long-term graft outcome.

Reinsmoen NL, Jackson AM, DeOliveira A, Matas AJ, Gillingham K, Ward FE.

Ann Transplant. 2000;5(2):50-60. Review. No abstract available.

PMID:
11217208
4.
5.

Transplantation of thymus tissue in complete DiGeorge syndrome.

Markert ML, Boeck A, Hale LP, Kloster AL, McLaughlin TM, Batchvarova MN, Douek DC, Koup RA, Kostyu DD, Ward FE, Rice HE, Mahaffey SM, Schiff SE, Buckley RH, Haynes BF.

N Engl J Med. 1999 Oct 14;341(16):1180-9.

6.

Interferon-beta1A-induced polyarthritis in a patient with the HLA-DRB1*0404 allele.

Levesque MC, Ward FE, Jeffery DR, Weinberg JB.

Arthritis Rheum. 1999 Mar;42(3):569-73. Review.

7.

Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, Myers LA, Ward FE.

N Engl J Med. 1999 Feb 18;340(7):508-16.

8.

Regional organ procurement (ROP) trays in renal allograft distribution and outcome.

MacQueen JM, Sanfilippo FP, Thacker L, Ward FE.

Clin Transplant. 1997 Oct;11(5 Pt 2):488-92.

PMID:
9361947
9.

Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymus.

Markert ML, Kostyu DD, Ward FE, McLaughlin TM, Watson TJ, Buckley RH, Schiff SE, Ungerleider RM, Gaynor JW, Oldham KT, Mahaffey SM, Ballow M, Driscoll DA, Hale LP, Haynes BF.

J Immunol. 1997 Jan 15;158(2):998-1005.

PMID:
8993022
10.

Mutations in purine nucleoside phosphorylase deficiency.

Markert ML, Finkel BD, McLaughlin TM, Watson TJ, Collard HR, McMahon CP, Andrews LG, Barrett MJ, Ward FE.

Hum Mutat. 1997;9(2):118-21.

PMID:
9067751
11.

Immunogenetic factors that may contribute to ethnic differences in renal allograft survival.

Ward FE, MacQueen JM.

Clin Transplant. 1996 Dec;10(6 Pt 2):620-4.

PMID:
8996754
12.

Baboon and cotton-top tamarin B2m cDNA sequences and the evolution of primate beta 2-microglobulin.

Ruiz RE, Hall BL, Doyle C, Ward FE.

Hum Immunol. 1994 Mar;39(3):188-94.

PMID:
8026986
13.

Rapid HLA-DR oligotyping by an enzyme-linked immunosorbent assay performed in microtiter trays.

Kostyu DD, Pfohl J, Ward FE, Lee J, Murray A, Amos DB.

Hum Immunol. 1993 Oct;38(2):148-58.

PMID:
8106269
14.

Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.

Buckley RH, Schiff SE, Schiff RI, Roberts JL, Markert ML, Peters W, Williams LW, Ward FE.

Semin Hematol. 1993 Oct;30(4 Suppl 4):92-101; discussion 102-4. Review.

PMID:
7905667
15.

Structural diversity in the HLA-A10 family of alleles: correlations with serology.

Madrigal JA, Hildebrand WH, Belich MP, Benjamin RJ, Little AM, Zemmour J, Ennis PD, Ward FE, Petzl-Erler ML, du Toit ED, et al.

Tissue Antigens. 1993 Feb;41(2):72-80.

PMID:
8475492
16.

Serologic cross-reactivities poorly reflect allelic relationships in the HLA-B12 and HLA-B21 groups. Dominant epitopes of the alpha 2 helix.

Hildebrand WH, Madrigal JA, Belich MP, Zemmour J, Ward FE, Williams RC, Parham P.

J Immunol. 1992 Dec 1;149(11):3563-8.

PMID:
1385528
17.

Distinctive HLA-A,B antigens of black populations formed by interallelic conversion.

Madrigal JA, Belich MP, Hildebrand WH, Benjamin RJ, Little AM, Zemmour J, Ennis PD, Ward FE, Petzl-Erler ML, du Toit ED, et al.

J Immunol. 1992 Nov 15;149(10):3411-5.

PMID:
1431115
18.

The molecular basis for reactivity of anti-Cw1 and anti-Cw3 alloantisera with HLA-B46 haplotypes.

Zemmour J, Gumperz JE, Hildebrand WH, Ward FE, Marsh SG, Williams RC, Parham P.

Tissue Antigens. 1992 May;39(5):249-57.

PMID:
1384166
19.

The use of DNA heteroduplex patterns to map recombination within the HLA class II region.

Carrington M, White MB, Dean M, Mann D, Ward FE.

Hum Immunol. 1992 Feb;33(2):114-21.

PMID:
1532959
20.

Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.

Storkus WJ, Salter RD, Alexander J, Ward FE, Ruiz RE, Cresswell P, Dawson JR.

Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5989-92.

22.

Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics.

Hall RP, Clark RE, Ward FE.

J Am Acad Dermatol. 1990 Mar;22(3):436-9.

PMID:
2312829
23.

Comparison of class I MHC alleles in humans and apes.

Lawlor DA, Warren E, Ward FE, Parham P.

Immunol Rev. 1990 Feb;113:147-85. Review. No abstract available.

PMID:
1690682
24.

Epitopes within the HLA-B5,B35 cross-reacting group.

Ward FE, Stewart AD, Ruiz RE, Killian P, Amos DB, Johnson AH, Kostyu DD.

Hum Immunol. 1989 Nov;26(3):151-67.

PMID:
2481660
25.

A high proportion of ADA point mutations associated with a specific alanine-to-valine substitution.

Markert ML, Norby-Slycord C, Ward FE.

Am J Hum Genet. 1989 Sep;45(3):354-61.

26.

HLA genotypes and variant alleles in Sudanese families of Arab-Negroid tribal origin.

Ward FE, Jensen JB, Abdul Hadi NH, Stewart A, Vande Waa JV, Bayoumi RA.

Hum Immunol. 1989 Apr;24(4):239-51.

PMID:
2708086
27.

Human leukocyte antigens and disease.

Ward FE, Amos DB.

Immunol Ser. 1989;43:359-78. Review. No abstract available.

PMID:
2490503
28.

HLA-A and B polymorphisms predate the divergence of humans and chimpanzees.

Lawlor DA, Ward FE, Ennis PD, Jackson AP, Parham P.

Nature. 1988 Sep 15;335(6187):268-71.

PMID:
3412487
30.

1,25-Dihydroxyvitamin D3 decreases expression of HLA class II molecules in a melanoma cell line.

Carrington MN, Tharp-Hiltbold B, Knoth J, Ward FE.

J Immunol. 1988 Jun 1;140(11):4013-8.

PMID:
3372995
32.

Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency.

Markert ML, Hershfield MS, Wiginton DA, States JC, Ward FE, Bigner SH, Buckley RH, Kaufman RE, Hutton JJ.

J Immunol. 1987 May 15;138(10):3203-6.

PMID:
3571974
34.

Use of DNA probes from the 5' flanking region of the HLA-B gene to examine polymorphism at the HLA-B locus.

Steere K, Sidwell B, Leach R, Ward FE, Taurog JD, Orr HT.

Hum Immunol. 1986 Jun;16(2):137-47.

PMID:
3013813
35.

Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.

Buckley RH, Schiff SE, Sampson HA, Schiff RI, Markert ML, Knutsen AP, Hershfield MS, Huang AT, Mickey GH, Ward FE.

J Immunol. 1986 Apr 1;136(7):2398-407.

PMID:
2869085
36.

Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies.

Parham P, Antonelli P, Herzenberg LA, Kipps TJ, Fuller A, Ward FE.

Hum Immunol. 1986 Jan;15(1):44-67.

PMID:
2419285
37.

Comparison of multiple HLA-A alleles at the DNA level by using Southern blotting and HLA-A-specific probes.

Koller BH, Ward FE, DeMars R, Orr HT.

J Immunol. 1985 Dec;135(6):4229-34.

PMID:
2415606
38.

Color discrimination as a function of saturation, field size, and adaptation level.

Ward FE, Greene F, Martin W.

Aviat Space Environ Med. 1985 Mar;56(3):251-3.

PMID:
3985906
39.

Successful immune reconstitution in severe combined immunodeficiency despite Epstein-Barr virus and cytomegalovirus infections.

DeVoe PW, Buckley RH, Shirley LR, Darby CP, Ward FE, Mickey GH, Raab-Traub N, Vandenbark GR.

Clin Immunol Immunopathol. 1985 Jan;34(1):48-59.

PMID:
2981167
40.

Severe combined immunodeficiency with natural killer-cell predominance: abrogation of graft-versus-host disease and immunologic reconstitution with HLA-identical bone marrow cells.

Sindel LJ, Buckley RH, Schiff SE, Ward FE, Mickey GH, Huang AT, Naspitz C, Koren H.

J Allergy Clin Immunol. 1984 Jun;73(6):829-36.

PMID:
6233355
41.

Monocyte suppression of antigen-specific lymphocyte responses in diffuse cutaneous leishmaniasis patients from the Dominican Republic.

Petersen EA, Neva FA, Barral A, Correa-Coronas R, Bogaert-Diaz H, Martinez D, Ward FE.

J Immunol. 1984 May;132(5):2603-6.

PMID:
6201552
43.

SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity.

Radka SF, Machamer C, Cresswell P, Kostyu DD, Ward FE, Amos DB.

J Immunol. 1983 Apr;130(4):1863-6.

PMID:
6187822
44.

Homogeneous substrate-labeled fluorescent immunoassay for carbamazepine.

Li TM, Miller JE, Ward FE, Burd JF.

Epilepsia. 1982 Aug;23(4):391-8.

PMID:
7047157
45.

DR antigens on melanoma cells: analysis with monoclonal antibodies.

Mitchell KF, Ward FE, Koprowski H.

Hum Immunol. 1982 Feb;4(1):15-26.

PMID:
6949895
46.

Lymphocyte suppressor activity in patients with polyglandular failure.

Verghese MW, Ward FE, Eisenbarth GS.

Hum Immunol. 1981 Oct;3(2):173-9.

PMID:
6460015
47.

Antimicrobial 3-methyleneflavanones.

Ward FE, Garling DL, Buckler RT, Lawler DM, Cummings DP.

J Med Chem. 1981 Sep;24(9):1073-7.

PMID:
7288822
48.

Familial predisposition to filarial infection--not linked to HLA-A or-B locus specificities.

Ottesen EA, Mendell NR, MacQueen JM, Weller PF, Amos DB, Ward FE.

Acta Trop. 1981 Sep;38(3):205-16.

PMID:
6171153
49.

Chimpanzee antibodies to purified human Ia-like B cell antigens.

Ward FE, Johnson AH, Metzgar RS, Strong DM, Cresswell P.

Transplantation. 1981 Jul;32(1):45-7. No abstract available.

PMID:
6973850
50.

A homogeneous fluorescent immunoassay for human immunoglobulin M.

Worah D, Yeung KK, Ward FE, Carrico RJ.

Clin Chem. 1981 May;27(5):673-7.

Supplemental Content

Support Center